Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
As a component of an N-hydroxylated prodrug-converting complex required to reduce N-hydroxylated prodrugs, such as benzamidoxime. Additionally we are shipping MOCO Sulphurase C-terminal Domain Containing 1 Proteins (8) and MOCO Sulphurase C-terminal Domain Containing 1 Kits (6) and many more products for this protein.
Showing 10 out of 29 products:
Human Polyclonal MOSC1 Primary Antibody for IHC (p), WB - ABIN653710
Plitzko, Ott, Reichmann, Henderson, Wolf, Mendel, Bittner, Clement, Havemeyer: The involvement of mitochondrial amidoxime reducing components 1 and 2 and mitochondrial cytochrome b5 in N-reductive metabolism in human cells. in The Journal of biological chemistry 2013
Show all 2 Pubmed References
Functional characteristics of protein variants encoded by nonsynonymous single nucleotide polymorphisms in MARC1 and MARC2 (show MARC2 Antibodies) in healthy Caucasians were determined.
human mARC-1 and mARC-2 (show MARC2 Antibodies) are capable of catalyzing reduction of nitrite to NO through reaction with its molybdenum cofactor
Data indicate that mitochondrial amidoxime reducing components 1 and 2 together with the electron transport proteins NADH-cytochrome b5 reductase (show CYB5RL Antibodies) (CYB5R) and cytochrome b5 (CYB5 (show CYB5A Antibodies)) catalyze the reduction of N-hydroxylated compounds such as amidoximes.
The transmembrane domain of mARC1 shown to be sufficient for mitochondrial targeting and the N-terminal targeting signal to function as a supportive receptor for the outer mitochondrial membrane.
Chlamydomonas reinhardtii ARC (show NOL3 Antibodies) has a Zn-dependent activity and protein partners similar to human MARC1 and MARC2 (show MARC2 Antibodies).
results provide the first hints that mARC (show CCL7 Antibodies) might be involved in mitochondrial N(omega)-hydroxy-L-arginine (show GATM Antibodies) reduction and could be of physiological significance in affecting endogenous nitric oxide levels
Arc1 (show CDH1 Antibodies)(MOSC-1) and Arc2(MOSC-2 (show MARC2 Antibodies)) proteins are monomeric in their active forms.
molybdoprotein mARC1 is involved in the activation of N-hydroxylated prodrugs.
As a component of an N-hydroxylated prodrug-converting complex required to reduce N-hydroxylated prodrugs, such as benzamidoxime. Also able to reduce N(omega)-hydroxy-L-arginine (NOHA) and N(omega)-hydroxy-N(delta)-methyl-L-arginine (NHAM) into L-arginine and N(delta)-methyl-L-arginine, respectively (By similarity).
MOCO sulphurase C-terminal domain containing 1
, MOSC domain-containing protein 1, mitochondrial
, moco sulfurase C-terminal domain-containing protein 1
, molybdenum cofactor sulfurase C-terminal domain-containing protein 1
, MOCO sulphurase C-terminal domain containing-like
, MOCO sulphurase C-terminal domain containing 2